OBIO CEO Gail Garland Provides Opening Remarks at MDCC's Strategic Entry into the U.S. MedTech Market Seminar

OBIO CEO Gail Garland was asked by MDCC to provide opening remarks at their hotly anticipated Strategic Entry into the U.S. MedTech Market for Canadian Firms Seminar.

The Greater MSP and MDCC brought to Toronto 4 world-class experts with backgrounds in finance, reimbursement, talent management and the FDA.  Each shared their insights and tools for success for strategically entering into the U.S. MedTech market.

Many of the attendees are were focused on commercialization for their own companies and very interested in the juggernaut market that exists south of the border.

The goal of the seminar was to add clarity to some of the major considerations, and to provide participants with insider knowledge to help tackle some of the most significant decisions and challenges.

The Speakers:

Finance
Mr. Dan Estes,
Vice Chair of Mayo Clinic Ventures

For the presentation click here

Reimbursement
Dr. Daniel Lace,
Chief Medical Officer at Leaders in Medicine Inc.

For the presentation click here

FDA
Ms. Carol Vierling, 
Senior Principal Regulatory Advisor at Regulatory and Quality Solutions LLC

For the presentation click here

Talent Management
Mr. Frank Jaskulke,
Vice President, Member Services, The Medical Alley Association

For the presentation click here

Enjoy a gallery from the event below!